CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and can afford the risks. Trading CFDs is high risk and is not suitable for everyone. Refer to our PDS and Target Market Determination. AFSL 513393
Open platformOpen platform

Biomea Fusion to Participate in Upcoming Investor Conferences

By GlobeNewswire

SAN CARLOS, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company, today announced that members of its management team will participate in the following upcoming investor conferences:

  • Jefferies Global Healthcare Conference in London: Biomea will participate in a fireside chat discussion on November 19, 2026, at 8:30 EST, 1:30 p.m. GMT in London, England. Management will also participate in one-on-one investor meetings during the conference.

  • Citi's 2026 Global Healthcare Conference: Management will participate in one-on-one investor meetings on December 2, 2026, in Miami, Florida.

  • Piper Sandler 38th Annual Healthcare Conference: Biomea will participate in a fireside chat discussion on December 3, 2026, at 1:30 p.m. ET in New York, New York. Management will also participate in one-on-one investor meetings during the conference.

Live audio webcasts of the Jefferies and Piper Sandler presentations will be available on the News & Events page of the Investors & Media section of Biomea's website. Webcast replays will be available following each presentation.

About Biomea Fusion
Biomea Fusion is a clinical-stage biopharmaceutical company advancing oral small molecule therapies, icovamenib and BMF-650, for diabetes and obesity. These programs target metabolic disorders, a global health challenge affecting nearly half of Americans and one-fifth of the world’s population. Biomea’s mission is to deliver transformative treatments that restore health for patients living with diabetes, obesity, and related conditions. We aim to cure.

Visit us at biomeafusion.com and follow us on LinkedIn, X and Facebook. 
 
Contact:
Meichiel Jennifer Weiss
Sr. Director of Investor Relations and Corporate Development
ir@biomeafusion.com


Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.